Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Aralez completes sale of drug rights to Nuvo Pharmaceuticals for $110m

pharmaceutical-technologyJanuary 03, 2019

Tag: acquisition , Aralez , Nuvo Pharmaceuticals , Vimovo

PharmaSources Customer Service